Medications

Sanofi shuts down factory over toxic waste outcry

French pharmaceuticals group Sanofi announced late Monday an immediate halt in production at a chemical factory in southwest France, in the wake of media reports that toxic waste emissions exceeded the norms.

Diseases, Conditions, Syndromes

US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine

Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus epidemic.

Medications

US firm Advent to buy Sanofi's generics unit

US private equity firm Advent International has agreed to acquire Zentiva, French pharmaceutical giant Sanofi's European generics arm, for 1.9 billion euros ($2.4 billion), a statement said Tuesday.

Other

Coronavirus boosts sales for French pharma giant Sanofi

French pharmaceutical giant Sanofi said Friday that its first quarter sales surged in part due to stockpiling of the painkiller Doliprane, as other companies around the world struggle during the coronavirus pandemic.

Vaccination

Novavax asks EU drug regulator to OK its COVID vaccine

The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...

page 5 from 13